Feb 23 |
HRMY vs. TECH: Which Stock Is the Better Value Option?
|
Feb 23 |
Q4 2023 Harmony Biosciences Holdings Inc Earnings Call
|
Feb 22 |
Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript
|
Feb 22 |
Harmony Biosciences Holdings, Inc. (HRMY) Q4 2023 Earnings Call Transcript
|
Feb 22 |
Harmony Biosciences Holdings, Inc. (HRMY) Misses Q4 Earnings and Revenue Estimates
|
Feb 22 |
Harmony Biosciences Holdings Inc (HRMY) Reports Robust Revenue Growth in Q4 and Full Year 2023
|
Feb 22 |
Harmony Biosciences Non-GAAP EPS of $0.73 misses by $0.18, revenue of $168.4M in-line
|
Feb 22 |
Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
|
Feb 21 |
Harmony Biosciences Q4 2023 Earnings Preview
|
Feb 21 |
U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSY
|